Last quarter (Q4 2022), Kuros Biosciences's total revenue was CHF―, a decrease of ― from the same quarter last year. In Q4, Kuros Biosciences's net income was CHF―. See Kuros Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	CHF 17.99M	CHF 13.81M	CHF 4.04M	CHF 2.56M	CHF 715.00K
Cost of Revenue	-	CHF 7.22M	CHF 3.75M	CHF 2.37M	CHF 2.22M	CHF 3.42M
Gross Profit	-	CHF 10.77M	CHF 10.07M	CHF 1.67M	CHF 341.00K	CHF -2.70M
Operating Expense	-	CHF 24.21M	CHF 18.83M	CHF 13.35M	CHF 11.73M	CHF 11.03M
Operating Income	-	CHF -13.45M	CHF -8.77M	CHF -11.68M	CHF -11.39M	CHF -13.73M
Net Non Operating Interest Income Expense	-	CHF -2.54M	CHF -787.00K	CHF -415.00K	CHF -431.00K	CHF -86.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	CHF -15.99M	CHF -9.55M	CHF -12.09M	CHF -11.82M	CHF -13.81M
Tax Provision	-	CHF -1.40M	CHF -2.01M	CHF -574.00K	CHF -571.00K	CHF -2.12M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	CHF -14.60M	CHF -7.54M	CHF -11.52M	CHF -11.25M	CHF -11.69M
Basic EPS	-	CHF -0.43	CHF -0.23	CHF -0.47	CHF -0.65	CHF -1.14
Diluted EPS	-	CHF -0.43	CHF -0.23	CHF -0.47	CHF -0.65	CHF -1.14
Basic Average Shares	-	CHF 33.90M	CHF 32.79M	CHF 24.32M	CHF 17.17M	CHF 10.24M
Diluted Average Shares	-	CHF 33.90M	CHF 32.79M	CHF 24.32M	CHF 17.17M	CHF 10.24M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	CHF 174.00K	CHF 1.17M
Total Expenses	-	CHF 31.43M	CHF 22.58M	CHF 15.72M	CHF 13.95M	CHF 14.44M
Net Income From Continuing And Discontinued Operation	-	CHF -14.60M	CHF -7.54M	CHF -11.52M	CHF -11.25M	CHF -11.69M
Normalized Income	-	CHF -14.60M	CHF -7.54M	CHF -11.52M	CHF -11.25M	CHF -11.69M
Interest Expense	-	CHF 4.32M	CHF 1.38M	CHF 848.00K	CHF 651.00K	CHF 126.00K
EBIT	-	CHF -11.67M	CHF -8.17M	CHF -11.25M	CHF -11.17M	CHF -13.69M
EBITDA	-	CHF -8.84M	CHF -5.29M	CHF -8.58M	CHF -8.46M	CHF -11.74M

Currency in CHF

Kuros Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing